BIOMAT Database Logo BIOMAT Database Logo

Microsomal metabolism of dimethylnitrosamine and the cytochrome P-450 dependency of its activation to a mutagen. 1973

P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D010777 Photochemistry A branch of physical chemistry which studies chemical reactions, isomerization and physical behavior that may occur under the influence of visible and/or ultraviolet light. Photochemistries
D011078 Polychlorinated Biphenyls Industrial products consisting of a mixture of chlorinated biphenyl congeners and isomers. These compounds are highly lipophilic and tend to accumulate in fat stores of animals. Many of these compounds are considered toxic and potential environmental pollutants. PCBs,Polychlorinated Biphenyl,Polychlorobiphenyl Compounds,Biphenyl, Polychlorinated,Biphenyls, Polychlorinated,Compounds, Polychlorobiphenyl
D002248 Carbon Monoxide Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed) Monoxide, Carbon
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450

Related Publications

P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Effects of cytochrome p-448 and p-450 inducers on microsomal dimethylnitrosamine demethylase activity and the capacity of isolated microsomes to activate dimethylnitrosamine to a mutagen.
June 1976, Mutation research,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Dimethylnitrosamine demethylation by reconstituted liver microsomal cytochrome P-450 enzyme system.
December 1975, The Biochemical journal,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Increased cytochrome P-450 independent drug metabolism and mutagen activation in rat liver by octachlorostyrene.
October 1983, Acta pharmacologica et toxicologica,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Metabolism of dichlorobiphenyls by hepatic microsomal cytochrome P-450.
March 1981, Biochemical pharmacology,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Metabolism of monochlorobiphenyls by hepatic microsomal cytochrome P-450.
March 1980, Biochemical pharmacology,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Vinylidene chloride: its metabolism by hepatic microsomal cytochrome P-450 in vitro.
June 1982, Biochemical pharmacology,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Tetrachloroethylene metabolism by the hepatic microsomal cytochrome P-450 system.
October 1980, Biochemical pharmacology,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
October 1984, Cancer research,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Aflatoxin B1 activation to a plasmid mutagen by a chemical model of cytochrome P-450.
January 1987, Mutation research,
P Czygan, and H Greim, and A J Garro, and F Hutterer, and F Schaffner, and H Popper, and O Rosenthal, and D Y Cooper
Cytochrome P-450 and halothane metabolism. Decrease in rat liver microsomal P-450 in vitro.
June 1983, Chemico-biological interactions,
Copied contents to your clipboard!